Halozyme Therapeutics, Inc. - Common Stock (NQ: HALO )

58.29 -0.32 (-0.55%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist

Insider Filings

Form 4
Source: SEC/Edgar
February 03, 2011
Form 3
Source: SEC/Edgar
December 12, 2010
Form 3
Source: SEC/Edgar
December 12, 2010
Form 4
Source: SEC/Edgar
May 09, 2010
Form 4
Source: SEC/Edgar
May 05, 2010
Form 4
Source: SEC/Edgar
May 05, 2010
Form 4
Source: SEC/Edgar
May 05, 2010
Form 4
Source: SEC/Edgar
May 05, 2010
Form 4
Source: SEC/Edgar
May 05, 2010
Form 4
Source: SEC/Edgar
February 07, 2010
Form 4
Source: SEC/Edgar
February 07, 2010
Form 4
Source: SEC/Edgar
February 07, 2010
Form 4
Source: SEC/Edgar
February 07, 2010
Form 4
Source: SEC/Edgar
February 07, 2010
Form 4
Source: SEC/Edgar
January 13, 2010
Form 4
Source: SEC/Edgar
August 06, 2009
Form 3
Source: SEC/Edgar
July 26, 2009
Form 4
Source: SEC/Edgar
May 07, 2009
Form 4
Source: SEC/Edgar
May 07, 2009
Form 4
Source: SEC/Edgar
May 07, 2009
Form 4
Source: SEC/Edgar
May 07, 2009
Form 4
Source: SEC/Edgar
May 07, 2009
Form 4
Source: SEC/Edgar
May 07, 2009
Form 3
Source: SEC/Edgar
April 22, 2009
Form 4
Source: SEC/Edgar
February 08, 2009
Form 4
Source: SEC/Edgar
February 08, 2009
Form 4
Source: SEC/Edgar
February 08, 2009
Form 4
Source: SEC/Edgar
February 08, 2009
Form 4
Source: SEC/Edgar
February 08, 2009
Form 4
Source: SEC/Edgar
December 17, 2008
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.